SCHEMBL20328587

SCHEMBL20328587

CCCC[Si](CCCC)(CCCC)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20328584 0.80
SCHEMBL29187827 0.78 TSHR (0.40) TSHRLMNATHRB
SCHEMBL30432424 0.78 TSHR (0.40) TSHRLMNATHRB
SCHEMBL27850694 0.75 TSHR (0.35) TSHRLMNATHRB
SCHEMBL5704625 0.73 NR1H2 (0.34) TSHRLMNATHRB
SCHEMBL20328580 0.73 TSHR (0.33) TSHRLMNATHRB
SCHEMBL8763793 0.73 TSHR (0.33) TSHRLMNATHRB
SCHEMBL6300378 0.71 TSHR (0.32) TSHRLMNATHRB
SCHEMBL6307616 0.71 TSHR (0.32) TSHRLMNATHRB
SCHEMBL6300395 0.71 TSHR (0.32) TSHRLMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179120-A1 Atropisomers and Methods of Altering Enantiomeric Excess FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179120-A1 Atropisomers and Methods of Altering Enantiomeric Excess CYP11B2, CYP21A2, CYP11B1 TSHR 2049/4885LMNA 2207/4885THRB 1702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.